carvedilol has been researched along with digoxin in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 17 (53.13) | 29.6817 |
| 2010's | 9 (28.13) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brendel, E; De Mey, C; Enterling, D | 1 |
| Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M | 1 |
| Cleland, JG | 1 |
| Bigger, JT; Bloomfield, DM; Goldsmith, RL; Krum, H; Packer, M; Sackner-Bernstein, J; Steinman, RC | 1 |
| Delea, TE; Fowler, MB; Oster, G; Richner, RE; Vera-Llonch, M | 1 |
| Eichhorn, EJ; Lukas, MA; Shusterman, N; Wu, B | 1 |
| Bergemann, A; Candy, G; Sareli, P; Skudicky, D; Sliwa, K | 1 |
| Bertsch, T; Feuring, M; Jester, I; Kugler, I; Schmidt, BM; Tillmann, HC; Wehling, M | 1 |
| Kakumoto, M; Kita, T; Kobayashi, H; Nakamura, T; Okamura, N; Okumura, K; Sakaeda, T; Takara, K; Yagami, T | 1 |
| Benson, L; Costei, AM; Griffiths, K; Koren, G; Ratnapalan, S | 1 |
| Gallup, DS; Gattis, WA; Gheorghiade, M; Hasselblad, V; O'Connor, CM | 1 |
| Gheorghiade, M; Lukas, MA | 1 |
| Naccarelli, GV | 1 |
| Kowey, PR | 1 |
| Auge, D; Bachmakov, I; Endress, B; Fromm, MF; Werner, U | 1 |
| Baris, N; Bozdemir, V; Güneri, S; Guven, H; Kalkan, S | 1 |
| Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
| Clark, AL; Witte, KK | 1 |
| Mitchell, LB | 1 |
| Altenberger, H; Finsterer, J; Stöllberger, C | 1 |
| Alabd, A; Gamal, A; Rayan, M; Tawfik, M | 1 |
| Chew, PG; Cleland, JG; Douglas, H; Jan, A; Jones, J; Khand, AU | 1 |
| Barros, RB; Marques, EB; Neri, JS; Scaramello, CB; Souza, FC | 1 |
| Malebranche, R; Morisset, PH; Raphael, NA; Tabou Moyo, C; Wilentz, JR | 1 |
| Balmer, C; Caduff Good, A; Cavigelli, A; Klauwer, D; Moser-Bracher, A; Satir, A | 1 |
| Franken, PR; Woltersdorf, R | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Alshammari, EM; Batiha, GE; Onohuean, H; Qusti, S | 1 |
8 review(s) available for carvedilol and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Chronic Disease; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Propanolamines; Vasodilator Agents | 1997 |
Role of carvedilol in atrial fibrillation: insights from clinical trials.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Digoxin; Drug Therapy, Combination; Heart Failure; Humans; Propanolamines; Randomized Controlled Trials as Topic; Ventricular Remodeling | 2004 |
Antiadrenergic therapy in the control of atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Cardiac Output, Low; Carvedilol; Digoxin; Disease Progression; Humans; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
A review of carvedilol arrhythmia data in clinical trials.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Carbazoles; Carvedilol; Death, Sudden, Cardiac; Digoxin; Heart Failure; Humans; Metoprolol; Myocardial Infarction; Propanolamines; Randomized Controlled Trials as Topic | 2005 |
Carvedilol in the treatment of elderly patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Chronic Disease; Comorbidity; Digoxin; Heart Failure; Humans; Propanolamines; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Role of drug therapy for sustained ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Digoxin; Heart Conduction System; Humans; Hydantoins; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazolidines; Piperazines; Propanolamines; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sotalol; Tachycardia, Ventricular | 2008 |
Covid-19 and development of heart failure: mystery and truth.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardiotonic Agents; Carvedilol; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Digoxin; Heart Failure; Humans; SARS-CoV-2 | 2021 |
8 trial(s) available for carvedilol and digoxin
| Article | Year |
|---|---|
Carvedilol increases the systemic bioavailability of oral digoxin.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Biological Availability; Carbazoles; Carvedilol; Digoxin; Double-Blind Method; Drug Interactions; Electrocardiography; Humans; Injections, Intravenous; Male; Propanolamines | 1990 |
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Aerobiosis; Aged; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Drug Therapy, Combination; Exercise Therapy; Female; Forearm; Furosemide; Heart; Heart Failure; Humans; Hyperemia; Leg; Male; Middle Aged; Oxygen Consumption; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 1997 |
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Digoxin; Double-Blind Method; Drug Therapy, Combination; Exercise Tolerance; fas Receptor; Female; Humans; Male; Middle Aged; Pentoxifylline; Propanolamines; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha; Vasodilator Agents; Ventricular Function, Left | 2001 |
Impact of pharmacotherapy on lymphocyte volumes and activity of the Na+/H+ exchanger in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Cell Size; Digoxin; Diuretics; Drug Interactions; Enalapril; Female; Heart Failure; Humans; Leukocytes, Mononuclear; Lymphocytes; Male; Middle Aged; Propanolamines; Sodium-Hydrogen Exchangers; Treatment Outcome | 2001 |
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Digoxin; Diuretics; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Patient Discharge; Propanolamines; Prospective Studies; Treatment Outcome; United States | 2004 |
Influence of carvedilol on serum digoxin levels in heart failure: is there any gender difference?
Topics: Aged; Antihypertensive Agents; Area Under Curve; Carbazoles; Cardiotonic Agents; Carvedilol; Digoxin; Drug Interactions; Female; Heart Failure; Humans; Male; Propanolamines; Sex Characteristics; Time Factors | 2006 |
Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzazepines; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Drug Therapy, Combination; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Propanolamines; Prospective Studies; Spironolactone; Vasodilator Agents; Ventricular Premature Complexes | 2011 |
The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Biomarkers; Carbazoles; Carvedilol; Case-Control Studies; Digoxin; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines; Treatment Outcome; Ventricular Function, Left | 2015 |
16 other study(ies) available for carvedilol and digoxin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol; Chronic Disease; Digoxin; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Parasympathetic Nervous System; Propanolamines | 1997 |
Cost effectiveness of carvedilol for heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiotonic Agents; Carvedilol; Cost-Benefit Analysis; Digoxin; Diuretics; Drug Therapy, Combination; Health Care Costs; Heart Failure; Hospitalization; Humans; Life Expectancy; Markov Chains; Propanolamines; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Vasodilator Agents | 1999 |
Effect of concomitant digoxin and carvedilol therapy on mortality and morbidity in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Chronic Disease; Confidence Intervals; Digoxin; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Morbidity; Probability; Propanolamines; Proportional Hazards Models; Retrospective Studies; Survival Analysis | 2000 |
Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
Topics: Adrenergic beta-Antagonists; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Division; Cell Line; Daunorubicin; Digoxin; DNA, Complementary; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial Cells; Fluorouracil; HeLa Cells; Humans; Inhibitory Concentration 50; Kidney; Paclitaxel; Propanolamines; Swine; Transfection; Verapamil; Vinblastine | 2003 |
Digoxin-carvedilol interactions in children.
Topics: Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Digoxin; Drug Interactions; Female; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Propanolamines; Vasodilator Agents | 2003 |
Characterization of beta-adrenoceptor antagonists as substrates and inhibitors of the drug transporter P-glycoprotein.
Topics: Adrenergic beta-Antagonists; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bisoprolol; Caco-2 Cells; Carbazoles; Carvedilol; Cyclosporins; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Humans; Propanolamines; Propranolol; Time Factors | 2006 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Digoxin; Diuretics; Echocardiography; Furosemide; Heart Ventricles; Humans; Lisinopril; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Mosaicism; Phenotype; Propanolamines; Spironolactone; Turner Syndrome; Ventricular Dysfunction, Left | 2009 |
Should pharmacotherapy of digoxin be reviewed in male patients with heart failure in the case of association with carvedilol?
Topics: Adrenergic beta-Antagonists; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Carbazoles; Cardiotonic Agents; Carvedilol; Clinical Trials as Topic; Cross-Over Studies; Digoxin; Drug Interactions; Heart Failure; Humans; Male; Middle Aged; Propanolamines | 2015 |
Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Carbazoles; Cardiomyopathy, Dilated; Cardiotonic Agents; Carvedilol; Cohort Studies; Digoxin; Diuretics; Echocardiography; Electrocardiography; Female; Furosemide; Haiti; Heart Failure; Hospitalization; Hospitals, University; Hospitals, Urban; Humans; Hypertension; Male; Middle Aged; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Prospective Studies; Puerperal Disorders; Sex Distribution; Spironolactone; Stroke Volume; Young Adult | 2016 |
Digoxin Toxicity in a Neonate Caused by the Interaction with Carvedilol.
Topics: Adrenergic beta-Antagonists; Cardiovascular Agents; Carvedilol; Digoxin; Disease Progression; Heart Failure; Humans; Infant, Newborn | 2017 |
Risk of renal dysfunction in an elderly patient with chronic heart failure.
Topics: Aged, 80 and over; Atrial Fibrillation; Carbazoles; Carvedilol; Diclofenac; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Infarction; Potassium; Potentially Inappropriate Medication List; Propanolamines; Ramipril; Risk Factors; Spironolactone | 2016 |